Adrian N Hobden's Net Worth
$13.9 Million
Who is Adrian N Hobden?
Adrian N Hobden has an estimated net worth of $13.9 Million. This is based on reported shares across multiple companies, which include Myriad Pharmaceuticals, Inc., and MYRIAD GENETICS INC.
SEC CIK
Adrian N Hobden's CIK is 0001191076
Past Insider Trading and Trends
2008 was Adrian N Hobden's most active year for acquiring shares with 11 total transactions. Adrian N Hobden's most active month to acquire stocks was the month of August. 2008 was Adrian N Hobden's most active year for disposing of shares, totalling 13 transactions. Adrian N Hobden's most active month to dispose stocks was the month of August. 2009 saw Adrian N Hobden paying a total of $710,304.15 for 328,900 shares, this is the most they've acquired in one year. In 2009 Adrian N Hobden cashed out on 182,900 shares for a total of $3,366,934.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Myriad Pharmaceuticals, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.99% | 41.67K |
—
|
—
| 208.37K |
Sep 24
| |||
Form 4
| +20.78% | 28K |
$1.38 | $38,646.90 | 162.79K |
Apr 16
| |||
Form 4
| +17.42% | 20K |
$4.41 | $88,200.00 | 134.78K |
Mar 18
| |||
Form 4
| +4.06% | 4.48K |
$1.23 | $5,492.69 | 114.78K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 4
| +85.45% | 50K |
—
|
—
| 108.52K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MYRIAD GENETICS INC (MYGN) Snapshot price: $26.97
Pres. Myriad Pharmaceuticals
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +18.87% | 37.16K |
$10.76 | $399,949.61 | 234.07K |
Jun 8
| |||
Form 4
|
—
|
0
|
$18.20 | -$1,264,948.00 | 195.73K |
May 27
| |||
Form 4
| +9.97% | 17.74K |
$5.64 | $99,990.54 | 195.73K |
May 8
| |||
Form 4
|
—
|
0
|
$44.19 | -$1,891,622.40 | 88.99K |
Feb 5
| |||
Form 4
|
—
|
0
|
$32.69 | -$1,116,446.00 | 88.99K |
Dec 11
| |||
Form 4
| +31.02% | 21.07K |
$5.13 | $107,973.50 | 88.99K |
Sep 29
| |||
Form 4
| -6.86% | -5.00K |
$36.84 | -$976,887.50 | 67.92K |
Sep 23 - Sep 25
| |||
Form 4
|
—
|
0
|
$35.57 | -$60,388.00 | 72.92K |
Sep 19
| |||
Form 4
| +15.89% | 10K |
$35.81 | $20,567.50 | 72.92K |
Sep 17 - Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 4
|
—
|
0
|
$35.08 | -$1,645,197.96 | 62.92K |
Aug 25
| |||
Form 4
| +19.00% | 10K |
$5.13 | $51,250.00 | 62.62K |
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
| +10.59% | 5K |
$5.13 | $25,625.00 | 52.24K |
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 4
|
—
|
0
|
$27.57 | -$897,500.00 | 47.24K |
Scheduled
|
Sep 25
| ||
Form 4
|
—
|
0
|
$22.57 | -$348,750.00 | 46.78K |
Scheduled
|
May 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
$18.57 | -$134,375.00 | 46.78K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 4
|
—
|
0
|
$15.57 | -$104,425.00 | 45.65K |
Scheduled
|
Apr 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
$15.07 | -$40,227.00 | 44.17K |
Scheduled
|
Jan 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
| +7.41% | 3K |
$5.13 | $15,375.00 | 43.49K |
Aug 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||